Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Pan Afr Med J ; 36: 226, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33708317

RESUMEN

Congenital adrenal hyperplasia refers to a group of rare genetic disorders affecting the adrenal glands. 21-hydroxylase deficiency is the most prevalent and the most studied cause while the remaining enzymatic defects are less common, accounting for less than 10% of cases. We herein described the clinical, biological and molecular characteristics and outcome of patients of the same family diagnosed with 11-Beta-hydroxylase deficiency. The disorder was revealed by peripheral precocious puberty between the age of 2-3 years in males and by the virilization of the external genitalia in females. Genetics finding a homozygous p.Gly379Val mutation in the CYP11B1 gene. All patients received hydrocortisone supplementation therapy and mineralocorticoid-receptor antagonist. The females underwent a surgical correction of the ambiguous genitalia at the neonatal age. Long term follow-up revealed metabolic syndrome, obesity and hypertension in the first two patients, an impaired final height in the two females and hypokalemia in three patients.


Asunto(s)
Hiperplasia Suprarrenal Congénita/diagnóstico , Esteroide 11-beta-Hidroxilasa/genética , Hiperplasia Suprarrenal Congénita/genética , Hiperplasia Suprarrenal Congénita/fisiopatología , Adulto , Niño , Femenino , Estudios de Seguimiento , Humanos , Hidrocortisona/administración & dosificación , Masculino , Antagonistas de Receptores de Mineralocorticoides/administración & dosificación , Mutación , Pubertad Precoz/etiología , Túnez
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA